Rising Prevalence Of Infectious Diseases Driving The Growth Of The Market Due To Increasing Risk Of Infections Leading To Pleural Complications: A Significant Driver Propelling The Pleural Diseases Market In 2025

The Pleural Diseases Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Pleural Diseases Market Size and Projected Growth Rate?
The market for pleural diseases has seen significant growth in recent years. The market value is anticipated to increase from $4.86 billion in 2024 to $5.23 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The growth in the past years can be credited to an increased frequency of pleural effusion, heightened public knowledge about pleural diseases, an increased emphasis on early detection, the expansion of healthcare facilities, and a rise in clinical trials relating to pleural diseases.

Expectations are that the market size for pleural diseases will experience significant growth in the years ahead, growing to a projected $6.94 billion by 2029 with a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period can be explained in part by increasing instances of pleural diseases, a growing older population, the rise of occupational hazards, the increase in clinical trials, and the expansion of diagnostic centers. The forecast period also predicts key trends such as diagnostic advancements, the development of improved diagnostic tools, the adoption of less invasive procedures, the progression of drug development, and the integration of telemedicine.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099

What Are the Major Segments in the Pleural Diseases Market?
The pleural diseases market covered in this report is segmented -

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types
2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions
3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy
4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:
1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy
2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax
3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma
4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma
5) Other Disease Types: Pulmonary Embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Are The Driving Pleural Diseases Market Evolution?
The growth of the pleural diseases market is anticipated to be fueled by the rising incidence of infectious diseases. These health conditions, which are caused by damaging microorganisms such as bacteria, viruses, fungi, or parasites, are becoming more common due to environmental alterations and changes in human behavior, as well as the advancement of global travel. Pleural diseases can be caused by infectious illnesses like bacterial pneumonia, tuberculosis, or viral infections, which provoke inflammation, infection, or fluid buildup in the pleural cavity. For example, in January 2023, the National Library of Medicine, a research and information medical library based in the US, reported that infectious diseases were responsible for over 52 million deaths each year, putting half of the world's population at risk. Furthermore, every year, around 14 million children under five years old succumb to death, with preventable diseases promptly accountable for 70% of these deaths. This increasing impact of infectious diseases is therefore propelling the expansion of the pleural diseases market.

Which Firms Dominate The Pleural Diseases Market Segments?
Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

What Trends Are Expected to Dominate the Pleural Diseases Market in the Next 5 Years?
Firms at the forefront of the pleural diseases market are concentrating on pioneering new treatment methods, for instance, evolving ready-to-use injectable therapies to enhance user-friendliness, cut down preparation time, and mitigate dosing missteps. Pre-diluted, pre-formulated medications are what these ready-to-use injectable treatments encompass, eliminating the need for mixing or reconstitution before utilization, thereby ensuring precision, practicality, and a shorter preparation timeline. For example, Amneal Pharmaceuticals, a pharmaceutical organization based in the United States, introduced PEMRYDI RTU, the pioneer ready-to-use variation of pemetrexed for injection in April 2024. This provides patients with pleural diseases a handy, ready-to-use solution that removes the necessity for dilution or reconstitution, trims down the preparation duration, managed the likelihood of dosing inaccuracies, and enhances the availability of potent therapy for conditions including malignant pleural mesothelioma.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Is The Largest Region In The Pleural Diseases Market?
North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pleural Diseases Market?
2. What is the CAGR expected in the Pleural Diseases Market?
3. What Are the Key Innovations Transforming the Pleural Diseases Industry?
4. Which Region Is Leading the Pleural Diseases Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.